Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people need to take Wegovy long-term to maintain the weight they lose. Clinical trial data and NHS guidance both indicate that stopping semaglutide typically leads to weight regain within months, which means duration isn't a fixed course but a decision shaped by your health goals, how your body responds, and your prescriber's assessment. As a prescription-only medicine, any decision about how long you stay on Wegovy should be made with a clinician — not guesswork.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision about how long you need to use Wegovy starts with understanding what the medicine is actually doing. Semaglutide works by acting on GLP-1 receptors involved in appetite regulation and gastric emptying, it doesn't reprogram your biology permanently. When you stop, those effects fade.
The STEP 1 trial, published in the New England Journal of Medicine, followed participants after they stopped semaglutide 2.4mg. Within a year of discontinuation, most had regained the majority of the weight they had lost. That finding shapes how prescribers think about duration. It doesn't mean everyone must take it indefinitely, but it does mean that planning to take it for three months and then stop is rarely a realistic strategy.
For practical context, think of Wegovy the way you might think about medication for blood pressure: the benefit exists while the treatment continues. The question isn't just "how long" but "what changes when I stop", and that's a conversation best had with your prescriber rather than based on a timeline set at the start of treatment.
The NHS patient information on semaglutide also notes that this medicine is used alongside a reduced-calorie diet and increased physical activity, which means the lifestyle work you do during treatment matters for what happens after it.
If you're trying to access Wegovy through the NHS, the framework is set by NICE technology appraisal TA875. It recommends semaglutide for up to a maximum of two years, delivered within a specialist weight management service that includes multidisciplinary support. There's also a specific checkpoint built in: if you haven't achieved at least 5% weight loss after six months at the maintenance dose, continuing treatment should be reconsidered.
That two-year ceiling applies specifically to NHS commissioning under TA875. Private prescribing operates under the medicine's licensed indication rather than NICE's commissioning rules, so the duration question looks different in a private setting, and is governed by ongoing clinical review rather than a fixed cap.
It's also worth knowing that treatment doesn't begin at the maintenance dose. Wegovy is titrated up gradually, from a low starting dose, over several months. That titration period is part of the overall treatment journey, and reaching the full maintenance dose can take the better part of a year in itself. So questions about how long Wegovy takes to work and how long you stay on it are genuinely linked.
Duration is ultimately a clinical decision, not a product feature. At each review, a prescriber will typically weigh several things: how much weight you've lost and whether loss is continuing, how you're tolerating the medicine, what your starting health picture looked like, and whether circumstances have changed (including pregnancy, a new diagnosis, or plans for surgery).
At nume, a GPhC-registered prescriber personally reviews every repeat order, not a script, not software, a real clinician. There's no auto-renewal; every order goes through fresh clinical assessment. That matters specifically for long-term treatment decisions, where circumstances six months in may be quite different from day one. If you're thinking about your own situation, our guide to individual Wegovy treatment length covers the personalised factors in more detail.
The cost of treatment over time is a legitimate part of the decision too. If you want to understand what ongoing Wegovy treatment costs privately, the Wegovy price page sets out what to expect, including what a transparent, all-in price actually covers.
One question our prescribers hear fairly regularly is: "Can I just take it for a few months and then stop?" The honest answer is that some people do successfully maintain weight loss after stopping, particularly if they've built sustainable habits during treatment, but the evidence suggests this is the exception rather than the rule, and it isn't predictable in advance.
Before you start Wegovy, it's worth being clear with your prescriber about your longer-term expectations. Are you aiming for a specific weight milestone? Do you have a health condition (such as hypertension or sleep apnoea) that the weight loss is intended to improve? Is cost a long-term consideration? These conversations help frame a realistic treatment plan rather than a loose commitment with no endpoint in mind.
Thinking about starting? Check your eligibility with our clinical team, consultations are free, and there's no obligation. You can also read more about how long Wegovy takes to produce meaningful weight loss if you're still working out whether it's the right fit, or visit our dedicated page on how long you have to take Wegovy for a fuller breakdown of what ongoing treatment typically involves.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.